|
Learn From Our Experts Presenting At The 2026 VEITHsymposium
VEITHsymposium’s 2026 scientific agenda remains the most complete educational program, offering outstanding sessions designed to keep you current on the latest advances in vascular surgery and endovascular therapies, led by leading experts in the field.
| | |
Joseph Shalhoub, MBBS, PhD | |
The Expanding Role Of PCSK-9 Inhibitor Drugs In Patients With Lower Extremity Atherosclerotic Occlusive Disease: What Drugs Are Available Or On The Horizon: When And How Should They Be Used In These And All Vascular Patients | | |
Technical Aspects To Enhance Successful Distal Dissection Stents In Petticoat And STABILISE Configurations To Treat Aortic Dissections: How To Assure Precise Stent Deployment, Avoid Aortic Injury, And Maximize Late Remodeling |
|
| |
|
"End Of The Line" Options For Hemodialysis Access
| | |
Endovascular Arterial Thrombo-Embolectomy Devices: Percutaneous Mechanical Thrombectomy: What's The Difference Between Them: Penumbra, AngioJet, Pounce, Artix, Rotarex, Jeti, Aventus, Excipio, Prodigy, Symphony, Versalio, Etc.: What's Coming Down The Road |
|
Loay S. Kabbani, MD, MHSA | | |
|
Size Thresholds For Repair Of AAAs Are Wrong On The Low Side: Data From Medicare And The VQI Indicate That Rupture Risk Only Increases With AAAs Over 6-6.9 cm |
| |
The ViTAA AI System For Analysis Of CT Factors Determining AAA Wall Weakness/Strength Of Areas In AAAs Predicts Rupture Risk Independent Of Size And Post EVAR Neck Behavior: How Does It Work And How Accurate Is It | |
| |
|
The Gore TAMBE Device For Complex AAAs And TAAAs: Advantages, Limitations, Technical Tips And Lessons Learned
| | |
Recipe For Long -Term Success In Access Creation And Maintenance
|
|
| |
Armando Mansilha, MD, PhD |
|
A Systematic Review And Meta-Analysis Of Randomized Controlled Trials Comparing Thermal And Nonthermal Ablation
| | |
The Role Of Mini-EVLA And Micro-EVLA In The Treatment Of Aesthetic Veins On The Face |
| | | | |
